Factors Affecting Non-Adherence to Secondary Stroke Prevention Therapy in Ischemic Stroke Patients

Stroke is cardiovascular disease that causes the world's highest disability and is the most prevalence disease after heart disease and cancer. Stroke is caused by circulatory disorders with 80% of the sufferers are diagnosed with ischemic stroke and 20% of them are diagnosed with hemorrhagic st...

Full description

Saved in:
Bibliographic Details
Main Authors: Zakky Cholisoh (Author), Hidayah Karuniawati (Author), Tanti Azizah (Author), Zaenab Zaenab (Author), Laila Nur Hekmah (Author)
Format: Book
Published: Universitas Gadjah Mada, 2018-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_441c075760a14c5f8dfe325c2bae6719
042 |a dc 
100 1 0 |a Zakky Cholisoh  |e author 
700 1 0 |a Hidayah Karuniawati  |e author 
700 1 0 |a Tanti Azizah  |e author 
700 1 0 |a Zaenab Zaenab  |e author 
700 1 0 |a Laila Nur Hekmah  |e author 
245 0 0 |a Factors Affecting Non-Adherence to Secondary Stroke Prevention Therapy in Ischemic Stroke Patients 
260 |b Universitas Gadjah Mada,   |c 2018-07-01T00:00:00Z. 
500 |a 2088-8139 
500 |a 2443-2946 
500 |a 10.22146/jmpf.34434 
520 |a Stroke is cardiovascular disease that causes the world's highest disability and is the most prevalence disease after heart disease and cancer. Stroke is caused by circulatory disorders with 80% of the sufferers are diagnosed with ischemic stroke and 20% of them are diagnosed with hemorrhagic stroke. Patients who survive from the first stroke have high risk to have recurrent stroke. American Heart Association/American Stroke Association and Perhimpunan Dokter Spesialis Syaraf Indonesia recommend secondary stroke prevention therapy including antiplatelet/anticoagulant, antihypertensive agents, and antidislipidemia to minimalize the risk of recurrent stroke. Secondary stroke prevention therapy is only the first step. Patients need to be adhere to those therapies. The non-adherence will increase the risk of recurrent stroke. The study aimed to determine factors which causing the non-adherence to secondary prevention therapy in patients with ischemic stroke. This was a case control study with concecutive sampling method by interviewing patients who met the inclusion criterias i.e., had been diagnosed and were inpatients due to ischemic stroke, but in the time of interview patients were outpatients, patients were able to communicate and agree to participate in the study.Data was analized by bivariate / chi square test and multivariate logistic regression test. During the study period, 184 respondents met the inclusion criterias. Factors affecting non-adherence in the use of secondary prevention therapy were No one reminded to take medicine p = 0.03; OR 4.51, denial of the disease p = 0,036 OR 214, and tired of taking medicine p = 0,045 OR 1,97. 
546 |a ID 
690 |a ischemic stroke 
690 |a recurrent stroke 
690 |a secondery stroke therapy 
690 |a non adherence 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Jurnal Manajemen dan Pelayanan Farmasi, Vol 8, Iss 2, Pp 90-99 (2018) 
787 0 |n https://jurnal.ugm.ac.id/jmpf/article/view/34434 
787 0 |n https://doaj.org/toc/2088-8139 
787 0 |n https://doaj.org/toc/2443-2946 
856 4 1 |u https://doaj.org/article/441c075760a14c5f8dfe325c2bae6719  |z Connect to this object online.